Description
Julius Baer Capital (India) Private Limited has listed 4000 commercial papers of Rs. 5 lakh each on BSE Debt segment, rated CRISIL A1+ and ICRA A1+, with redemption date of February 10, 2026.
Summary
Julius Baer Capital (India) Private Limited has listed new commercial papers on BSE’s Debt segment effective November 11, 2025. The listing consists of 4000 commercial papers issued on a private placement basis, each with a face value of Rs. 5,00,000. The securities are rated CRISIL A1+ and ICRA A1+, with HDFC Bank Limited acting as the Issuing and Paying Agent.
Key Points
- Quantity Issued: 4000 commercial papers
- Face Value: Rs. 5,00,000 per unit
- Issue Price: Rs. 4,91,604.50 per unit (issued at discount)
- Market Lot: 1 unit
- Scrip Code: 730530
- Scrip ID: JBCP111125
- Detail Name: JBCIPL-10-02-26-CP
- ISIN: INE824H14ST5
- Credit Rating: CRISIL A1+, ICRA A1+
- Trading Format: Dematerialised form only
- Tick Size: 1 paise
- Issuing and Paying Agent: HDFC Bank Limited
Regulatory Changes
No regulatory changes introduced. This is a standard new instrument listing notification.
Compliance Requirements
- Trading members must trade these securities only in dematerialized form under ISIN INE824H14ST5
- Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
- Securities will be traded on BSE Debt segment only
- For clarifications, trading members may contact the debt department at 22728352/8597/8995/5753/8915
Important Dates
- Notice Date: November 11, 2025
- Date of Allotment: November 11, 2025
- Listing Date: November 11, 2025
- Redemption Date: February 10, 2026
- Tenure: Approximately 91 days
Impact Assessment
This is a routine commercial paper listing with minimal market impact. The listing adds short-term debt instruments to BSE’s debt segment, providing institutional investors with additional money market investment options. The high credit ratings (A1+ from both CRISIL and ICRA) indicate strong creditworthiness. The discount pricing (issue price below face value) reflects standard commercial paper market practices. No impact on equity markets or retail investors.
Impact Justification
Routine commercial paper listing on private placement basis with no impact on equity markets or broader trading operations